posted on 2023-08-22, 14:20authored byKanika Jain, Ian C. Henrich, Laura Quick, Robert Young, Shreya Mondal, Andre M. Oliveira, Gerd A. Blobel, Margaret M. Chou
Flow antibodies used
Funding
HHS | National Institutes of Health (NIH)
Sarcoma Foundation of America (SFA)
Kids Beating Cancer
State of Pennsylvania Department of Health
History
ARTICLE ABSTRACT
This study provides novel insights into the immunomodulatory functions of USP6, the only cancer cell–intrinsic factor demonstrated to regulate the immune TME in Ewing sarcoma. We demonstrate that USP6-mediated suppression of Ewing sarcoma tumorigenesis is dependent on NK cells. USP6 directly activates NK cell cytolytic function, inducing both intratumoral and systemic activation of NK cells in an Ewing sarcoma xenograft model.